Knight Thomas F. Jr. 13D and 13G filings for Ginkgo Bioworks Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 5:08 pm Sale | 2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Knight Thomas F. Jr. | 1,708,211 4.100% | -165,192 (-8.82%) | Filing |
2023-02-14 5:01 pm Sale | 2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Knight Thomas F. Jr. | 1,873,403 5.000% | -3,673 (-0.20%) | Filing |
2022-02-14 7:57 pm Sale | 2021-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Knight Thomas F. Jr. | 1,877,076 5.700% | -2,500 (-0.13%) | Filing |
2021-09-28 4:31 pm Purchase | 2021-09-16 | 13G | Ginkgo Bioworks Holdings, Inc. DNA | Knight Thomas F. Jr. | 1,879,576 5.600% | 1,879,576 (New Position) | Filing |